Adaptive Biotechnologies Corp (ADPT)
Adaptive Biotechnologies Corporation, founded in 2009 and headquartered in Seattle, Washington (operating as Adaptive TCR Corporation until its name change in December 2011), is a commercial-stage entity focused on pioneering an immune medicine platform. This advanced platform is engineered for the precise diagnosis and effective treatment of a broad spectrum of illnesses. The company offers several core technological solutions. Its immunoSEQ platform, a foundational immunosequencing product, is vital for translational research and discovering novel prognostic and diagnostic markers. For confirming past COVID-19 infections, Adaptive provides T-Detect COVID. Additionally, clonoSEQ functions as a critical clinical diagnostic tool, enabling the detection and continuous monitoring of minimal residual disease in individuals with multiple myeloma, B-cell acute lymphoblastic leukemia, and chronic lymphocytic leukemia; it is also available as a CLIA-validated laboratory-developed test for other lymphoid cancers. Another specialized offering, immunoSEQ T-MAP COVID, aids vaccine developers and researchers in quantifying T-cell immune responses to vaccines. Beyond its current product lineup, Adaptive Biotechnologies actively develops a pipeline of clinical products and services designed for the diagnosis, monitoring, and treatment of conditions such as cancer, autoimmune disorders, and infectious diseases. Its solutions cater to life science research, clinical diagnostics, and drug discovery applications. The company has established key strategic collaborations: one with Genentech, Inc., for the joint development, manufacturing, and commercialization of neoantigen-directed T-cell therapies aimed at treating various cancers; and another with Microsoft Corporation, dedicated to creating sophisticated diagnostic tests capable of identifying multiple diseases early from a single blood sample.
Sector: Biological Products, (No Diagnostic Substances)
Industry: Biotechnology
Adaptive Biotechnologies Corporation
No splits on record
Nothing in ADPT's public trading history: no forward or reverse split has affected the share count.
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 |
| Revenue | $276.98M | $178.96M | $170.28M | $185.31M | $154.34M | $98.38M | $85.07M | $55.66M | $38.45M |
| YoY Growth | 54.8% | 5.1% | -8.1% | 20.1% | 56.9% | 15.6% | 52.8% | 44.8% | - |
| Cost of Revenue | $71.36M | $72.08M | $75.55M | $57.91M | $49.3M | $22.53M | $22.27M | $19.67M | $15.68M |
| Gross Profit | $205.62M | $106.88M | $94.72M | $127.4M | $105.04M | $75.85M | $62.8M | $35.99M | $22.77M |
| Gross Margin | 74.2% | 59.7% | 55.6% | 68.7% | 68.1% | 77.1% | 73.8% | 64.7% | 59.2% |
| Research and Development | $93.77M | $102.95M | $122.12M | $141.76M | $142.34M | $116.07M | $70.7M | $39.16M | $32M |
| Selling, General, and Administrative | $167.27M | $157.56M | $172.51M | $184.13M | $169.97M | $110.89M | $68.78M | $44.9M | $32.71M |
| Other | $1.7M | $8.91M | $27.13M | $1.7M | $1.7M | $1.7M | $1.7M | $1.7M | $1.69M |
| Total Operating Expenses | $262.74M | $269.43M | $321.76M | $327.58M | $314.01M | $228.67M | $141.19M | $85.75M | $66.4M |
| Operating Income (EBIT) | -$57.12M | -$162.55M | -$227.03M | -$200.19M | -$208.97M | -$152.82M | -$78.39M | -$49.76M | -$44.48M |
| Operating Margin | -20.6% | -90.8% | -133.3% | -108.0% | -135.4% | -155.3% | -92.1% | -89.4% | -115.7% |
| Interest Expense | $11.78M | $11.58M | $13.8M | $4.24M | $0 | $0 | $0 | $0 | $0 |
| Interest Income | $9.44M | $14.53M | $15.53M | $4.06M | $1.67M | $6.59M | $9.79M | $3.31M | $1.64M |
| Other Income (Expense) | -$2.33M | $2.95M | $1.73M | -$182K | $1.67M | $6.59M | $9.79M | $3.31M | $1.64M |
| Income Before Tax (EBT) | -$59.46M | -$159.59M | -$225.3M | -$200.37M | -$207.3M | -$146.23M | -$68.61M | -$46.45M | -$42.83M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$59.5M | -$159.49M | -$225.25M | -$200.19M | -$207.28M | -$146.23M | -$68.61M | -$46.45M | -$42.83M |
| Net Income Margin | -21.5% | -89.1% | -132.3% | -108.0% | -134.3% | -148.6% | -80.6% | -83.4% | -111.4% |
| Supplementary Data | |||||||||
| EPS | -0.39 | -1.08 | -1.56 | -1.00 | -1.46 | -1.06 | -0.47 | -0.44 | -0.41 |
| Diluted EPS | -0.39 | -1.08 | -1.56 | -1.00 | -1.46 | -1.06 | -0.47 | -0.44 | -0.41 |
| Weighted Average OS | 151.72M | 147.10M | 144.38M | 142.52M | 140.35M | 131.22M | 124.34M | 105.43M | 105.43M |
| EBITDA | -$29.85M | -$128.76M | -$189.27M | -$175.21M | -$193.34M | -$144.34M | -$70.6M | -$43.76M | -$37.84M |
| EBITDA Margin | -10.8% | -71.9% | -111.2% | -94.6% | -125.3% | -146.7% | -83.0% | -78.6% | -98.4% |
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 |
| Assets | |||||||||
| Current Assets | |||||||||
| Cash and Cash Equivalents | $70.5M | $47.92M | $65.06M | $90.03M | $139.06M | $123.44M | $96.58M | $55.03M | $85.31M |
| Short-Term Investments | $156.49M | $174.37M | $281.34M | $408.17M | $214M | $564.83M | $480.29M | $109.99M | $106.84M |
| Cash and Short-Term Investments | $226.98M | $222.29M | $346.4M | $498.2M | $353.06M | $688.27M | $576.87M | $165.02M | $192.15M |
| Accounts Receivable | $50.37M | $41.73M | $37.97M | $40.06M | $17.41M | $10.05M | $12.68M | $4.81M | $5.58M |
| Inventory | $9.82M | $8.44M | $14.45M | $14.45M | $19.26M | $14.06M | $9.07M | $7.84M | $4.79M |
| Other Current Assets | $13.02M | $11.29M | $11.37M | $9.44M | $0 | $0 | $0 | $0 | $0 |
| Total Current Assets | $300.19M | $283.75M | $410.19M | $562.15M | $402.75M | $726.91M | $612.69M | $180.72M | $205.25M |
| Long-Term Assets | |||||||||
| Property, Plant & Equipment Net | $74.72M | $94.38M | $120.32M | $164.21M | $172.94M | $139.04M | $60.35M | $19.13M | $13.95M |
| Goodwill | $118.97M | $118.97M | $118.97M | $118.97M | $118.97M | $118.97M | $118.97M | $118.97M | $118.97M |
| Intangible Assets | $1.73M | $3.42M | $5.13M | $6.83M | $8.53M | $10.22M | $11.93M | $13.63M | $15.32M |
| Long-Term Investments | $15.92M | $33.66M | $0 | $0 | $217.15M | $118.53M | $105.44M | $247K | $8.9M |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$247K | $0 |
| Other Long-Term Assets | $1.21M | $5.18M | $6.52M | $4.46M | $3.01M | $2.74M | $2.92M | $247K | $86K |
| Total Long-Term Assets | $212.55M | $255.62M | $250.95M | $294.47M | $520.6M | $389.5M | $299.61M | $151.97M | $157.24M |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $512.74M | $539.38M | $661.13M | $856.62M | $923.34M | $1.12B | $912.3M | $332.69M | $362.49M |
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts Payable | $6.47M | $7.26M | $7.72M | $8.08M | $3.31M | $3.24M | $4.45M | $1.79M | $1.96M |
| Short-Term Debt | $13.56M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Income Tax Payable | $0 | $176K | $59K | $194K | $391K | $1.77M | $2.06M | $0 | $0 |
| Current Unearned Revenue | $45.19M | $55.69M | $48.63M | $64.11M | $80.46M | $73.32M | $60.99M | $12.7M | $14.05M |
| Other Current Liabilities | $7.7M | $16.7M | $13.69M | $15.94M | $15.64M | $11.95M | $8.49M | $3.67M | $1.93M |
| Total Current Liabilities | $89.92M | $98.05M | $88.02M | $109.79M | $113.81M | $105.2M | $78.31M | $22.8M | $21M |
| Long-Term Liabilities | |||||||||
| Long-Term Debt | $196.79M | $0 | $0 | $0 | $0 | $0 | $0 | $561.19M | $0 |
| Long-Term Unearned Revenue | $1.01M | $27.26M | $44.79M | $58.6M | $98.75M | $163.62M | $219.33M | $704K | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$561.19M | $0 |
| Other Long-Term Liabilities | -$70.21M | $132.43M | $130.66M | $125.36M | $0 | $0 | $7.01M | $6.1M | $566.1M |
| Total Long-Term Liabilities | $197.82M | $238.84M | $264.84M | $282.73M | $205.44M | $267.95M | $262.95M | $568M | $566.1M |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $287.74M | $336.89M | $352.86M | $392.52M | $319.24M | $373.15M | $341.26M | $590.8M | $587.11M |
| Stockholders' Equity | |||||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $561.19M | $561.67M |
| Common Stock | $15K | $14K | $14K | $14K | $14K | $14K | $12K | $1K | $1K |
| Retained Earnings | -$1.36B | -$1.3B | -$1.14B | -$919.08M | -$718.89M | -$511.61M | -$365.48M | -$295.91M | -$249.42M |
| Comprehensive Income & Other | $253K | $166K | $215K | -$4.12M | -$1.14M | $893K | $671K | -$107K | -$166K |
| Other Stockholders' Equity | $1.58B | $1.51B | $1.45B | $1.38B | $1.32B | $1.25B | $936.5M | $37.8M | $24.81M |
| Total Equity | $218.79M | $202.71M | $308.4M | $464.17M | $603.99M | $743.27M | $571.04M | -$258.11M | -$224.62M |
| Minority Interest | $6.21M | -$224K | -$121K | -$67K | $110K | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $506.53M | $539.6M | $661.25M | $856.68M | $923.23M | $1.12B | $912.3M | $332.69M | $362.49M |
| Supplementary Data | |||||||||
| Total Debt | $280.58M | $89.39M | $98.77M | $108M | $111.74M | $107.86M | $36.61M | $561.19M | $561.67M |
| Net Debt | $210.09M | $41.47M | $33.71M | $17.97M | -$27.32M | -$15.57M | -$59.97M | $506.16M | $476.37M |
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 |
| Operating Activities | |||||||||
| Net Income | -$59.5M | -$159.59M | -$225.25M | -$200.19M | -$207.28M | -$146.23M | -$68.61M | -$46.45M | -$42.83M |
| Depreciation & Amortization | $17.83M | $19.26M | $22.23M | $20.92M | $13.95M | $8.47M | $7.79M | $6M | $5.8M |
| Deferred Income Tax | $0 | $0 | $0 | $0 | $0 | $773K | -$1.88M | -$1.24M | $637K |
| Stock-Based Compensation | $51.48M | $53.61M | $0 | $0 | $0 | $24.76M | $13.12M | $11.15M | $7.01M |
| Changes in Working Capital: | |||||||||
| Accounts Receivable | -$8.65M | -$3.74M | $2.03M | -$22.65M | -$7.36M | $2.61M | -$7.82M | $775K | -$2.43M |
| Inventory | -$998K | $1.94M | -$2.84M | $817K | -$5.2M | -$4.99M | -$1.23M | -$3.05M | -$2.7M |
| Accounts Payable | $665K | $671K | -$5.41M | $7.11M | $3.94M | $5.25M | -$2.43M | $1.87M | -$1.84M |
| Other Working Capital | -$48.79M | -$16.32M | -$39.97M | -$56.83M | -$48.19M | -$43.66M | $266.41M | -$1.32M | $1.49M |
| Total Working Capital Change | -$57.77M | -$17.45M | -$46.18M | -$71.55M | -$56.82M | -$40.8M | $254.93M | -$1.72M | -$5.47M |
| Other Non-Cash Items | $1.96M | $8.97M | $92.88M | $66.87M | $57.41M | $3.34M | $43K | $5K | $6K |
| Net Cash from Operating | -$45.99M | -$95.21M | -$156.32M | -$183.94M | -$192.73M | -$149.68M | $205.4M | -$32.26M | -$34.86M |
| Investing Activities | |||||||||
| Capital Expenditures | -$2.96M | -$3.66M | -$10.7M | -$16.35M | -$61.75M | -$18.8M | -$11.2M | -$6.32M | -$2.51M |
| Acquisitions | $0 | $0 | $0 | $0 | $0 | $98.24M | $470.5M | $19K | $85K |
| Purchases of Investments | -$181.71M | -$244.26M | -$429.56M | -$278.78M | -$316.54M | -$694.97M | -$884.22M | -$146.5M | -$125.18M |
| Sales of Investments | $222.62M | $325.71M | $569.9M | $298.03M | $559.5M | $596.72M | $413.72M | $153.54M | $163.91M |
| Other Investing Activities | $0 | $0 | $0 | $0 | $0 | -$98.24M | -$470.5M | $19K | $122K |
| Net Cash from Investing | $37.95M | $77.79M | $129.65M | $2.9M | $181.21M | -$117.04M | -$481.7M | $736K | $36.43M |
| Financing Activities | |||||||||
| Debt Repaid | - | - | - | -$124.38M | - | - | - | - | - |
| Common Stock Issuance | $30.4M | $241K | $2.25M | $7.89M | $26.72M | $272.16M | $320.85M | $1.27M | $50.05M |
| Common Stock Repurchases | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | $0 | $0 | $0 | $0 | $429K | $21.43M | -$934K | $1.25M | $207K |
| Net Cash from Financing | $30.4M | $241K | $2.25M | $132.26M | $27.15M | $293.59M | $319.92M | $1.25M | $50.03M |
| Forex Effect | $0 | $0 | -$534K | -$260K | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | $22.37M | -$17.18M | -$24.97M | -$49.03M | $15.63M | $26.86M | $43.62M | -$30.27M | $51.61M |
| Supplementary Data | |||||||||
| Operating Cash Flow | -$45.99M | -$95.21M | -$156.32M | -$183.94M | -$192.73M | -$149.68M | $205.4M | -$32.26M | -$34.86M |
| Capital Expenditure | -$2.96M | -$3.66M | -$10.7M | -$16.35M | -$61.75M | -$18.8M | -$11.2M | -$6.32M | -$2.51M |
| Free Cash Flow | -$48.95M | -$98.88M | -$167.02M | -$200.29M | -$254.47M | -$168.49M | $194.2M | -$38.58M | -$37.36M |
| Cash at Beginning | $50.82M | $68M | $90.03M | $139.06M | $123.44M | $98.71M | $55.09M | $85.37M | $33.76M |
| Cash at End | $73.18M | $50.82M | $65.06M | $90.03M | $139.06M | $125.57M | $98.71M | $55.09M | $85.37M |